Stockreport

Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Ianalumab is an investigational monoclonal antibody with a novel dual mechanism of action, designed to deplete B-cells by targeting the BAFF receptor while inhibiting B [Read more]